These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Do defects in ion channel glycosylation set the stage for lethal cardiac arrhythmias? Fozzard HA; Kyle JW Sci STKE; 2002 Apr; 2002(130):pe19. PubMed ID: 11983936 [TBL] [Abstract][Full Text] [Related]
30. Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome. Nuyens D; Stengl M; Dugarmaa S; Rossenbacker T; Compernolle V; Rudy Y; Smits JF; Flameng W; Clancy CE; Moons L; Vos MA; Dewerchin M; Benndorf K; Collen D; Carmeliet E; Carmeliet P Nat Med; 2001 Sep; 7(9):1021-7. PubMed ID: 11533705 [TBL] [Abstract][Full Text] [Related]
31. Intracellular calcium attenuates late current conducted by mutant human cardiac sodium channels. Potet F; Beckermann TM; Kunic JD; George AL Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):933-41. PubMed ID: 26022185 [TBL] [Abstract][Full Text] [Related]
32. A novel mechanism for LQT3 with 2:1 block: a pore-lining mutation in Nav1.5 significantly affects voltage-dependence of activation. Horne AJ; Eldstrom J; Sanatani S; Fedida D Heart Rhythm; 2011 May; 8(5):770-7. PubMed ID: 21193062 [TBL] [Abstract][Full Text] [Related]
33. Long QT syndrome: from channels to cardiac arrhythmias. Moss AJ; Kass RS J Clin Invest; 2005 Aug; 115(8):2018-24. PubMed ID: 16075042 [TBL] [Abstract][Full Text] [Related]
34. Unraveling the genetics and mechanisms of cardiac arrhythmia. Noble D Proc Natl Acad Sci U S A; 2002 Apr; 99(9):5755-6. PubMed ID: 11983875 [No Abstract] [Full Text] [Related]
35. Can common genetic variations combine to produce the long QT syndrome phenotype? Kaufman ES Heart Rhythm; 2005 Jul; 2(7):748-9. PubMed ID: 15992733 [No Abstract] [Full Text] [Related]
36. Studying cardiac arrhythmias in the mouse--a reasonable model for probing mechanisms? Nerbonne JM Trends Cardiovasc Med; 2004 Apr; 14(3):83-93. PubMed ID: 15121155 [TBL] [Abstract][Full Text] [Related]
37. A revised view of cardiac sodium channel "blockade" in the long-QT syndrome. Kambouris NG; Nuss HB; Johns DC; Marbán E; Tomaselli GF; Balser JR J Clin Invest; 2000 Apr; 105(8):1133-40. PubMed ID: 10772658 [TBL] [Abstract][Full Text] [Related]
38. QT interval prolongation and cardiac risk assessment for novel drugs. Picard S; Lacroix P Curr Opin Investig Drugs; 2003 Mar; 4(3):303-8. PubMed ID: 12735231 [TBL] [Abstract][Full Text] [Related]
39. Electromechanical window negativity in genotyped long-QT syndrome patients: relation to arrhythmia risk. ter Bekke RM; Haugaa KH; van den Wijngaard A; Bos JM; Ackerman MJ; Edvardsen T; Volders PG Eur Heart J; 2015 Jan; 36(3):179-86. PubMed ID: 25205533 [TBL] [Abstract][Full Text] [Related]
40. The molecular genetics of the long QT syndrome: genes causing fainting and sudden death. Vincent GM Annu Rev Med; 1998; 49():263-74. PubMed ID: 9509262 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]